This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lehman, C. W. Articles by Botchan, M. R. Search for Related Content PubMed PubMed Citation Articles by Lehman, C. W. Articles by Botchan, M. R.

 Previous Article  |  Next Article 

J. Virol., May 1997, 3652-3665, Vol 71, No. 5
Copyright © 1997, American Society for Microbiology

A papillomavirus E2 phosphorylation mutant exhibits normal transient replication and transcription but is defective in transformation and plasmid retention

CW Lehman, DS King and MR Botchan
Department of Molecular and Cell Biology, University of California, Berkeley 94720-3204, USA. Lehman@mendel.berkeley.edu

Papillomavirus DNA persists in infected cells as a nuclear plasmid, causing epithelial lesions in many hosts, including humans. The viral protein E2 is required for both replication and transcription to facilitate this persistence. Bovine papillomavirus E2 protein is phosphorylated at two predominant sites. Phosphorylation of one of these sites (serine 301) inhibits replication of the genome. Using mass spectrometry and Edman sequencing, we have mapped additional phosphorylation sites in tryptic peptides to positions which lie primarily in the putatively unstructured hinge region of E2. Mutation of the major sites facilitates transformation in the absence of viral repressors and only has a minor effect on transformation when the repressors are present. Mutation of the major phosphorylation sites combined with one additional change at a newly discovered site (serine 235) blocks transformation. Transformation can be restored by mutating this residue to aspartic acid, mimicking a phosphorylated amino acid, suggesting that phosphorylation is key to the regulation. Transformation by the mutant genome can also be rescued by ectopic expression of the E2 enhancer protein, demonstrating a loss of function by the mutant protein and not a toxic defect. In transient assays, phosphorylation site mutants of E2 protein were normal for all viral functions tested, including replication, transcriptional activation and repression (by the overlapping mutant repressors), protein accumulation, and surprisingly, viral oncogene E5 promoter activation. While the mutant genome transiently replicated to high levels, stable replication was defective, suggesting that a function of E2 required for plasmid retention is regulated by phosphorylation.

This article has been cited by other articles:

• Kurg, R., Tekkel, H., Abroi, A., Ustav, M. (2006). Characterization of the Functional Activities of the Bovine Papillomavirus Type 1 E2 Protein Single-Chain Heterodimers. J. Virol. 80: 11218-11225 [Abstract] [Full Text]  
• Shire, K., Kapoor, P., Jiang, K., Hing, M. N. T., Sivachandran, N., Nguyen, T., Frappier, L. (2006). Regulation of the EBNA1 Epstein-Barr Virus Protein by Serine Phosphorylation and Arginine Methylation.. J. Virol. 80: 5261-5272 [Abstract] [Full Text]  
• Penrose, K. J., Garcia-Alai, M., de Prat-Gay, G., McBride, A. A. (2004). Casein Kinase II Phosphorylation-induced Conformational Switch Triggers Degradation of the Papillomavirus E2 Protein. J. Biol. Chem. 279: 22430-22439 [Abstract] [Full Text]  
• Coito, C., Diamond, D. L., Neddermann, P., Korth, M. J., Katze, M. G. (2004). High-Throughput Screening of the Yeast Kinome: Identification of Human Serine/Threonine Protein Kinases That Phosphorylate the Hepatitis C Virus NS5A Protein. J. Virol. 78: 3502-3513 [Abstract] [Full Text]  
• Voitenleitner, C., Botchan, M. (2002). E1 Protein of Bovine Papillomavirus Type 1 Interferes with E2 Protein-Mediated Tethering of the Viral DNA to Mitotic Chromosomes. J. Virol. 76: 3440-3451 [Abstract] [Full Text]  
• Steger, G., Schnabel, C., Schmidt, H.-M. (2002). The hinge region of the human papillomavirus type 8 E2 protein activates the human p21WAF1/CIP1 promoter via interaction with Sp1. J. Gen. Virol. 83: 503-510 [Abstract] [Full Text]  
• Bellanger, S., Demeret, C., Goyat, S., Thierry, F. (2001). Stability of the Human Papillomavirus Type 18 E2 Protein Is Regulated by a Proteasome Degradation Pathway through Its Amino-Terminal Transactivation Domain. J. Virol. 75: 7244-7251 [Abstract] [Full Text]  
• Penrose, K. J., McBride, A. A. (2000). Proteasome-Mediated Degradation of the Papillomavirus E2-TA Protein Is Regulated by Phosphorylation and Can Modulate Viral Genome Copy Number. J. Virol. 74: 6031-6038 [Abstract] [Full Text]  
• Stubenrauch, F., Hummel, M., Iftner, T., Laimins, L. A. (2000). The E8 ˆE2C Protein, a Negative Regulator of Viral Transcription and Replication, Is Required for Extrachromosomal Maintenance of Human Papillomavirus Type 31 in Keratinocytes. J. Virol. 74: 1178-1186 [Abstract] [Full Text]  
• Hou, S. Y., Wu, S.-Y., Zhou, T., Thomas, M. C., Chiang, C.-M. (2000). Alleviation of Human Papillomavirus E2-Mediated Transcriptional Repression via Formation of a TATA Binding Protein (or TFIID)-TFIIB-RNA Polymerase II-TFIIF Preinitiation Complex. Mol. Cell. Biol. 20: 113-125 [Abstract] [Full Text]  
• Calos, M. P. (1998). Stability without a centromere. Proc. Natl. Acad. Sci. USA 95: 4084-4085 [Full Text]  
• Lehman, C. W., Botchan, M. R. (1998). Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation. Proc. Natl. Acad. Sci. USA 95: 4338-4343 [Abstract] [Full Text]  
• Lim, D. A., Gossen, M., Lehman, C. W., Botchan, M. R. (1998). Competition for DNA Binding Sites between the Short and Long Forms of E2 Dimers Underlies Repression in Bovine Papillomavirus Type 1 DNA Replication Control. J. Virol. 72: 1931-1940 [Abstract] [Full Text]